DiaMedica Therapeutics Inc.
DMACNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $469.96M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.25$10.42
- Volume (live)
- -
- Avg. volume (3M)
- 221.36K
DiaMedica Therapeutics (DMAC) Stock Price & Financial Analysis
DiaMedica Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.29 - $8.79 |
|---|---|
| 52-Week High | $10.42 |
| 52-Week Low | $5.25 |
| Open | $8.55 |
| Volume (last close) | 110.03K |
| Average Volume (3M) | 221.36K |
| 50-Day MA | $7.24 |
|---|---|
| 200-Day MA | $7.08 |
| 1-Year Change | +27.66% |
| Market Cap | 469.96M |
|---|---|
| Shares Outstanding | 53.89M |
| Price to Book (P/B) | 12.26 |
| EV/EBITDA | -11.88 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
DiaMedica Therapeutics at a Glance
As of the Oct 23, 2026 close, DiaMedica Therapeutics (DMAC) has a market capitalization of $469.96M.
As of its latest reported balance sheet, it holds $5.13M in cash and securities against $185.00K of debt, a net cash position of $4.94M.
DiaMedica Therapeutics does not currently pay a dividend.
The share price is up 27.7% over the past year. At $8.72 (the Oct 23, 2026 close) it sits within its 52-week range of $5.25 to $10.42, above its 200-day moving average of $7.08.
Frequently Asked Questions About DiaMedica Therapeutics
What is the current stock price for DMAC?
As of the Oct 23, 2026 close, DMAC stock trades at $8.72. The 52-week range is $5.25–$10.42, with a day range of $8.29–$8.79.
What is the P/E ratio for DMAC?
The P/E ratio (Price-to-Earnings) for DMAC is shown in the Key Statistics section. This valuation metric helps compare DiaMedica Therapeutics Inc. to industry peers.
Does DMAC pay dividends?
DiaMedica Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for DMAC?
Analyst ratings and recommendations for DMAC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of DMAC?
As of the Oct 23, 2026 close, DiaMedica Therapeutics's market capitalization is $470.0M, classifying it as a small-cap company. DiaMedica Therapeutics operates in the Healthcare sector within the Biotechnology industry.